corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

All items in the Healthy Skepticism Library

All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.

Page 118 of 206 pages ‹ First  < 116 117 118 119 120 >  Last ›

HSL5541
Shah MB, Bentley JP, McCaffrey DJ 3rd.
Evaluations of care by adults following a denial of an advertisement-related prescription drug request: The role of expectations, symptom severity, and physician communication style.
Soc Sci Med 2006 Feb;62:(4):888-899
http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description

HSL8799
Mykytyn CE.
Anti-aging medicine: a patient/practitioner movement to redefine aging.
Soc Sci Med 2006 Feb;62:(3):643-53
http://linkinghub.elsevier.com/retrieve/pii/S0277-9536(05)00305-9

HSL8800
Hollander I.
Viagra's rise above women's health issues: an analysis of the social and political influences on drug approvals in the United States and Japan.
Soc Sci Med 2006 Feb;62:(3):683-93
http://linkinghub.elsevier.com/retrieve/pii/S0277-9536(05)00317-5

HSL9261
Engelhardt N, Feiger AD, Cogger KO, Sikich D, DeBrota DJ, Lipsitz JD, Kobak KA, Evans KR, Potter WZ.
Rating the raters: assessing the quality of Hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trials.
J Clin Psychopharmacol 2006 Feb;26:(1):71-4
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004714-200602000-00015

HSL11677
Wehling M.
Translational medicine: can it really facilitate the transition of research "from bench to bedside"?
Eur J Clin Pharmacol 2006 Feb;62:(2):91-5
http://www.springerlink.com/content/7782201555m7310x/

HSL12502
Groves T.
How honest can a medical journal be?
Aust N Z J Obstet Gynaecol 2006 Feb;46:(1):2-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1479-828X.2006.00505.x

HSL12595
Piette JD, Heisler M, Horne R, Caleb Alexander G.
A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.
Soc Sci Med 2006 Feb;62:(4):846-57
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4GV983T-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=3aa5f1b29cf6371fe25722c02e9b48e2

HSL13285
Kapmeyer A, Meyer C, Kochen MM, Himmel W.
Doctors' strategies in prescribing drugs: the case of mood-modifying medicines.
Fam Pract 2006 Feb;23:(1):73-9
http://fampra.oxfordjournals.org/cgi/content/full/23/1/73

HSL4764
Laupacis A.
On bias and transparency in the development of influential recommendations.
CMAJ 2006 Jan 31;174:(3):335-6
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=16446476

HSL4778
Romano M.
Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
Mod Healthc 2006 Jan 30;36:(5):8-10

HSL4824
Prescription drug package inserts get a user-friendly makeover.
Med Health 2006 Jan 30;60:(6):2-3,

HSL4737
Lenzer J.
US agency wants to limit lawsuits against drug manufacturers.
BMJ 2006 Jan 28;332:(7535):196
http://bmj.bmjjournals.com/cgi/content/full/332/7535/196-d

HSL4996
Global Framework for Essential Health R&D
CONSUMERS INTERNATIONAL 2006 Jan 26

HSL19952
Ed.
Pressure test your brand strategy
eyeforpharma.com 2006 Jan 26
http://social.eyeforpharma.com/marketing/pressure-test-your-brand-strategy

HSL3828
Connolly C.
Distance Sought Between Doctors and Drug Industry
Distance Sought Between Doctors and Drug Industry 2006 Jan 25
http://www.washingtonpost.com/wp-dyn/content/article/2006/01/24/AR2006012401483.html

HSL4776
Jarhult B.
[Let the profit from drug advertisement in Lakartidningen go to a research foundation!].
Lakartidningen 2006 Jan 25-31;103:(4):226

HSL4841
Harris G.
In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
NY Times (Print) 2006 Jan 25;A14:

HSL7447
Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, Goldman J, Kassirer JP, Kimball H, Naughton J, Smelser N.
Health industry practices that create conflicts of interest: a policy proposal for academic medical centers.
JAMA 2006 Jan 25;295:(4):429-33
http://jama.ama-assn.org/cgi/content/full/295/4/429

HSL4779
Food and Drug Administration, HHS.
Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Fed Regist 2006 Jan 24;71:(15):3921-97
http://a257.g.akamaitech.net/7/257/2422/01jan20061800/edocket.access.gpo.gov/2006/pdf/06-545.pdf

HSL4739
Fontanarosa PB, DeAngelis CD.
JAMA's policy on industry sponsored studies.
BMJ 2006 Jan 21;332:(7534):177
http://bmj.bmjjournals.com/cgi/content/full/332/7534/177

HSL4765
Herrling P.
Experiments in social responsibility.
Nature 2006 Jan 19;439:(7074):267-8
http://www.nature.com/doifinder/10.1038/439267a

HSL4740
Clarke JT.
Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy.
CMAJ 2006 Jan 17;174:(2):189-90
http://www.cmaj.ca/cgi/content/full/174/2/189

HSL8519
Lexchin J.
Is there still a role for spontaneous reporting of adverse drug reactions?
CMAJ 2006 Jan 17;174:(2):191-2
http://www.cmaj.ca/cgi/content/full/174/2/191

HSL4889
Cina J, Fanikos J, Mitton P, McCrea M, Churchill W.
Medication errors in a pharmacy-based bar-code-repackaging center.
Am J Health Syst Pharm 2006 Jan 15;63:(2):165-8
http://www.ajhp.org/cgi/content/full/63/2/165

HSL4709
Day M.
UK drug companies must disclose funding of patients' groups.
BMJ 2006 Jan 14;332:(7533):69
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16410564&db=PubMed&url=http://bmj.com/cgi/pmidlookup?view=long&pmid=16410564

HSL3672
Henderson D.
Glaxo plans sales curbs for diet pill
The Boston Globe 2006 Jan 13
http://www.boston.com/business/healthcare/articles/2006/01/13/glaxo_plans_sales_curbs_for_diet_pill/

HSL4710
Fisher CB.
Public health. Clinical trials results databases: unanswered questions.
Science 2006 Jan 13;311:(5758):180-1
http://www.sciencemag.org/cgi/content/full/311/5758/180

HSL3673
Genentech/Biogen Idec: wearing the drug marketing suit well?
Pharmaceutical Business Review 2006 Jan 12
http://www.pharmaceutical-business-review.com/article_feature.asp?guid=5C379035-9AD6-4724-AB96-3ABBD2D9B871

HSL3674
Kang P.
Forest Labs' Mylan Deal Alleviates Pipeline Concerns
Forbes.com 2006 Jan 12
http://www.forbes.com/technology/sciences/2006/01/12/forest-labs-mylan-nebivolol-0112markets03.html

HSL3675
Watts W.
Senators question research grants: Grassley: 'Educational' grants used for drug marketing
MarketWatch 2006 Jan 11
http://www.marketwatch.com/news/yhoo/story.asp?source=blq/yhoo&siteid=yhoo&dist=yhoo&guid=%7BC11F8C93%2D3FD4%2D4119%2DBBC5%2D71B607F8DD5D%7D

HSL3586
Ayers C.
The rise of the rah-rah reps
Times Online 2006 Jan 9
http://www.timesonline.co.uk/article/0,,8123-1973793,00.html

HSL3498
Abramson J.
Drug profits infect medical studies
Los Angeles Times 2006 Jan 7
http://www.latimes.com/news/printedition/opinion/la-oe-abramson7jan07,1,4571818.story

HSL1805
Society of General Internal Medicine
Policy on acceptance and disclosure of external funds
Society of General Internal Medicine 2006 Jan 6
http://www.sgim.org/PDF/SocietyInfo/ExternalFundsPolicyJan2006.pdf

HSL3494
Hensley S.
Pfizer Struggles As Generics Pummel Its Drugs
Hartford Courant ( courant.com) 2006 Jan 6
http://www.courant.com/business/hc-pfizer.artjan06,0,2429494.story?coll=hc-headlines-business

HSL3493
Glaxo says two of its drugs cause eye swelling
bizjournals.com 2006 Jan 5
http://biz.yahoo.com/bizj/060105/1211873.html?.v=1

HSL3496
Roche Holding Defends Drug Advertisement
Associated Press 2006 Jan 5
http://biz.yahoo.com/ap/060105/switzerland_roche_ad_dispute.html?.v=1

HSL3497
FDA Asks Advisory Committee To Examine Cardiovascular Risks Of ADHD Medications
kaisernetwork.org ( The Henry J. Kaiser Family Foundation) 2006 Jan 5
http://www.medicalnewstoday.com/medicalnews.php?newsid=35781

HSL3499
Use Of Nicotine Patches, Gum In First 12 Weeks Of Pregnancy Can Increase Risk Of Birth Defects, Study Says
kaisernetwork.org ( The Henry J. Kaiser Family Foundation) 2006 Jan 5
http://www.medicalnewstoday.com/medicalnews.php?category=41

HSL3495
Smith A.
The antidepressants to watch in '06
CNN/Money 2006 Jan 4
http://money.cnn.com/2006/01/04/news/companies/antidepressants/?cnn=yes

HSL3501
Rosen M.
Biotech flourishes in 2005 while Big Pharma is on the decline
Wisconsin Technology Network 2006 Jan 4
http://wistechnology.com/article.php?id=2582

HSL3580
Roner L.
Can pharma find new solutions to some old problems in 2006?
Eye For Pharma 2006 Jan 4
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=1/4/2006&news=49251

HSL3581
Armstrong J.
A new approach to pharmaceutical sales and marketing: Sustainable competitive advantage through psychographic segmentation
Eye For Pharma 2006 Jan 4
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=1/4/2006&news=49249

HSL4796
Junod AF.
[A misleading panacea?]
Rev Med Suisse 2006 Jan 4;2:(47):74

HSL3582
J&J Says It Missed 2 Deaths in Drug Study
Associated Press 2006 Jan 3
http://biz.yahoo.com/ap/060103/j_j_heart_drug.html?.v=2

HSL3583
Chu W.
Penicillin and Amoxicillin's days are numbered
in-Pharma Technologist.com 2006 Jan 3
http://www.in-pharmatechnologist.com/news/ng.asp?n=64680-antibiotic-resistance-penicillin-amoxicillin

HSL3584
New Year's Eve Viagra ad labelled 'reckless'
PM live .com 2006 Jan 3
http://www.pmlive.com/doaa/news.cfm?showArticle=1&ArticleID=4293

HSL3585
Larger companies still withholding trials info, says study
PM Live.com 2006 Jan 3
http://www.pmlive.com/pharm_market/news.cfm?showArticle=1&ArticleID=4296

HSL4763
By the numbers. Top 20 pharmaceutical companies, ranked by U.S. sales, October 2004 to September 2005.
Mod Healthc. 2006 Jan 2;36:(1):30

HSL3488
Berenson A.
Antidepressants Seem to Cut Suicide Risk in Teenagers and Adults, Study Says
New York Times 2006 Jan 1
http://query.nytimes.com/search/query?ppds=bylL&v1=ALEX%20BERENSON&fdq=19960101&td=sysdate&sort=newest&ac=ALEX%20BERENSON&inline=nyt-per

HSL3489
Savodnik I.
Psychiatry's sick compulsion: turning weaknesses into diseases
Los Angeles Times 2006 Jan 1
http://www.latimes.com/news/opinion/sunday/editorials/la-op-psych1jan01,0,1868753.story?coll=la-home-sunday-opinion

HSL4547
Fuchs J, Hippius M, Schaefer M.
Analysis of German package inserts.
Int J Clin Pharmacol Ther 2006 Jan;44:(1):8-13

HSL4858
Wallace LS, Rogers ES, Turner LW, Keenum AJ, Weiss BD.
Suitability of written supplemental materials available on the Internet for nonprescription medications.
Am J Health Syst Pharm 2006 Jan 1;63:(1):71-8
http://www.ajhp.org/cgi/content/full/63/1/71

HSL4866
Young A.
'Can you prescribe something?'
Health Aff (Millwood). 2006 Jan-Feb;25(1):226-30. 2006 Jan-Feb 01;25:(1):226-30
http://content.healthaffairs.org/cgi/content/full/25/1/226

HSL4934
Wolfson W.
Holding back the tide of antibiotic resistance.
Chem Biol 2006 Jan 01;13:(1):1-3
http://linkinghub.elsevier.com/retrieve/pii/S1074-5521(06)00005-6

HSL4935
Roche AM, James MF, Grocott MP, Mythen MG.
Just scratching the surface: varied coagulation effects of polymer containers on TEG variables.
Eur J Anaesthesiol 2006 Jan 01;23:(1):45-9
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3288&uid=16390565&db=PubMed&url=http://journals.cambridge.org/abstract_S0265021505001754

HSL5123
O'Connor EJ, Fiol CM.
Creating readiness and involvement.
Physician Exec 2006 Jan-Feb 01;32:(1):72-4

HSL5124
Lyles A.
Creating alternative incentives for pharmaceutical innovation.
Clin Ther 2006 Jan 01;28:(1):126-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4J9820V-F&_coverDate=01%2F31%2F2006&_alid=413875430&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0974efb1c817dae9d0e3f0198037cbff

HSL5142
Friedman LS, Richter ED.
Excessive and disproportionate advertising in peer-reviewed journals.
Int J Occup Environ Health 2006 Jan-Mar 01;12:(1):59-64

HSL5144
Chan CH.
The pharmaceutical role.
Acad Psychiatry 2006 Jan-Feb 01;30:(1):45-7
http://ap.psychiatryonline.org/cgi/content/full/30/1/45

HSL5145
Lazarus A.
The role of the pharmaceutical industry in medical education in psychiatry.
Acad Psychiatry 2006 Jan-Feb 01;30:(1):40-4
http://ap.psychiatryonline.org/cgi/content/full/30/1/40

HSL5146
Jibson MD.
Medical education and the pharmaceutical industry: managing an uneasy alliance.
Acad Psychiatry 2006 Jan-Feb 01;30:(1):36-9
http://ap.psychiatryonline.org/cgi/content/full/30/1/36

HSL5157
Skiba M.
Strategies for identifying and minimizing medication errors in health care settings.
Health Care Manag (Frederick) 2006 Jan-Mar 01;25:(1):70-7
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00126450-200601000-00010http://

HSL5160
Kondrak G, Dorr B.
Automatic identification of confusable drug names.
Artif Intell Med 2006 Jan 01;36:(1):29-42
http://linkinghub.elsevier.com/retrieve/pii/S0933-3657(05)00100-4

HSL5180
Global Corruption Report 2006.
: Transparency International 2006
http://www.transparency.org/publications/gcr/download_gcr

HSL5652
Chur-Hansen A, Zion D.
'Let's fix the chemical imbalance first, and then we can work on the problems second': an exploration of ethical implications of prescribing an SSRI for 'depression'.
Monash Bioeth Rev 2006 Jan 01;25:(1):15-30

HSL5675
Sethi M, Mishra D.
Display of feeding bottles in advertising renditions.
Indian J Pediatr 2006 Jan 01;73:(1):104-5
http://www.ijppediatricsindia.org/article.asp?issn=0019-5456;year=2006;volume=73;issue=1;spage=104;epage=105;aulast=Sethi

HSL5780
Yoon EY, Davis MM, El-Essawi H, Cabana MD.
FDA labeling status of pediatric medications.
Clin Pediatr (Phila) 2006 Jan-Feb 01;45:(1):75-7

HSL5830
De Santo NG.
[Promoting clinical research].
G Ital Nefrol 2006 Jan-Feb 01;23:

HSL5834
Wen LS, McCoy C.
Response to 'Interactions between pharmaceutical representatives and doctors in training: a thematic review'.
J Gen Intern Med 2006 Jan 01;21:(1):103
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.00271_4.x

HSL5835
Goodman RL, Carrasquillo O.
The corporate co-author, the ghostwriter, and the medical society: an object lesson (June, 2005 issue).
J Gen Intern Med 2006 Jan 01;21:(1):102
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.00271_3.x

HSL5943
Kossoff EH, Mankad DN.
Medication-overuse headache in children: is initial preventive therapy necessary?
J Child Neurol 2006 Jan 01;21:(1):45-8
http://www.bcdecker.com/pubMedLinkOut.aspx?pub=JCNO&vol=21&iss=1&page=45

HSL6189
Vogenberg FR, Dhir S.
Have consultant pharmacists provided value to long-term care payers?
Consult Pharm 2006 Jan 01;21:(1):72-5

HSL6311
O'Malley P.
Pharmaceutical advertising and clinical nurse specialist practice.
Clin Nurse Spec 2006 Jan-Feb 01;20:(1):13-5
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00002800-200601000-00005

HSL4711
Flynn G.
The NIH ethics crackdown: a message to the research community.
Ann Emerg Med 2006 Jan;47:(1):57-60

HSL4741
Aaronson DW.
The 'black box' and allergy drugs
J Allergy Clin Immunol 2006 Jan;117:(1):40-4
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16387582&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02125-1

HSL4743
Murphy S, Roberts R.
'Black box' 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
J Allergy Clin Immunol 2006 Jan;117:(1):34-9
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02325-0

HSL4744
Pearlman DS.
Primum non nocere and 'black box' warnings.
J Allergy Clin Immunol 2006 Jan;117:(1):30-1
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02116-0

HSL4745
Szefler SJ, Whelan GJ, Leung DY.
'Black box' warning: wake-up call or overreaction?
J Allergy Clin Immunol 2006 Jan;117:(1):26-9
http://linkinghub.elsevier.com/retrieve/pii/S0091-6749(05)02509-1

HSL4805
Brekke KR, Kuhn M.
Direct to consumer advertising in pharmaceutical markets.
J Health Econ 2006 Jan;25:(1):102-30
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8K-4HHH4T3-1&_coverDate=01%2F31%2F2006&_alid=403641655&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5873&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d15efcddeb52424f0d0d469a23fe6bca

HSL4810
Prescription for trouble: common drugs, hidden dangers Tens of people are at risk.
Consum Rep 2006 Jan;71:(1):34-9

HSL4811
Drug-name game.
Consum Rep 2006 Jan;71:(1):9

HSL4812
Frantz S.
Pharma's year of trouble and strife.
Nat Rev Drug Discov 2006 Jan;5:(1):7-9

HSL4813
Jayaraman KS.
Firms discovering reality of clinical research in India.
Nat Rev Drug Discov 2006 Jan;5:(1):6

HSL4820
Meadows M.
Promoting safe and effective drugs for 100 years.
FDA Consum 2006 Jan-Feb;40:(1):14-20
http://www.fda.gov/fdac/features/2006/106_cder.html

HSL4821
Warning on unapproved alternative hormone therapies.
FDA Consum 2006 Jan-Feb;40:(1):2
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=4686&uid=16528817&db=PubMed&url=http://www.fda.gov/fdac/departs/2006/106_upd.html#hormone

HSL4833
Privitera M.
Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Epilepsy Res 2006 Jan;68:(1):52-6
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16377139&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0920-1211(05)00250-0

HSL4848
Windmeijer F, de Laat E, Douven R, Mot E.
Pharmaceutical promotion and GP prescription behaviour.
Health Econ 2006 Jan;15:(1):5-18
http://www3.interscience.wiley.com/cgi-bin/abstract/110504860/ABSTRACT

HSL4863
Pfizer and Humana join forces on new Medicare Health Support Program.
Dis Manag Advis 2006 Jan;12:(1):8-9,

HSL4886
Marnell T.
A big issue?
Br J Gen Pract 2006 Jan;56:(522):57
http://www.ingentaconnect.com/content/rcgp/bjgp/2006/00000056/00000522/art00011?token=004c17f309b4e7268293c62207d673f582f6b6d383a4b3b257b507b6d7a416a387c6b4654276

HSL4887
Finucane TE.
Advertising the new hypnotics.
J Am Geriatr Soc 2006 Jan;54:(1):170
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2005.00575_1.x

HSL5073
Bhatt A, Sewlikar S.
Registering clinical trials in India.
Natl Med J India 2006 Jan-Feb;19:(1):1-3

HSL5074
Almirall N.
The ethics of engagement with the pharmaceutical industry.
Mich Med 2006 Jan-Feb;105:(1):10-2

HSL5079
Breen KJ, Rogers W.
Physicians and the pharmaceutical industry.
Intern Med J 2006 Jan;36:(1):66-7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2005.00993.x

HSL7530
Vallance P, Smart TG.
The future of pharmacology.
Br J Pharmacol 2006 Jan;147:
http://www.nature.com/bjp/journal/v147/n1s/abs/0706454a.html

HSL7700
Thunell L, Milsom I, Schmidt J, Mattsson LA.
Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
BJOG 2006 Jan;113:(1):15-20
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1471-0528.2005.00805.x

HSL7702
Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force.
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends.
Hypertension 2006 Jan;47:(1):22-8
http://hyper.ahajournals.org/cgi/content/full/47/1/22

HSL7703
Panthee S.
Evaluation of prescribing errors in primary care.
Int J Clin Pharmacol Ther 2006 Jan;44:(1):50
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16425971&query_hl=32&itool=pubmed_docsum

HSL7717
Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Menopause 2006 Jan-Feb;13:(1):125-9
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/01.gme.0000191211.51232.9d

HSL10905
Rockhold FW.
Requiring 'independent' statistical analyses for industry sponsored trials?
Pharm Stat 2006 Jan-Mar;5:(1):5-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17080923&dopt=Abstract

HSL11951
Moghimi Y.
The 'PharmFree' campaign: educating medical students about industry influence.
PLoS Med 2006 Jan;3:(1):e30
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030030

Page 118 of 206 pages ‹ First  < 116 117 118 119 120 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.